Morgan Stanley Calls Merck (MRK) a 'Catalyst Driven Idea' Ahead of March 6 Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Morgan Stanley calls Merck (MRK) a 'Catalyst Driven Idea' ahead of ACC conference
February 14, 2023 12:41 PM ESTMorgan Stanley reiterated an Equal Weight rating and $99.00 price target on Merck & Co., Inc. (NYSE: MRK) ahead of the companys appearance at the ACC conference on Mar 6. MRK will present data from two pipeline CV drugs at the conference -... More
Merck (MRK) PT Raised to $125 at Credit Suisse
February 13, 2023 5:52 AM ESTCredit Suisse analyst Trung Huynh raised the price target on Merck (NYSE: MRK) to $125.00 (from $120.00) while maintaining a Outperform rating.... More
Citi Closes Catalyst Watch Merck (MRK)
February 9, 2023 10:42 AM ESTCiti analyst Andrew Baum reiterated a Neutral rating and $106.00 price target on Merck (NYSE: MRK).
The analyst comments "This Upside Catalyst Watch call, opened on 9-Nov-2022, has expired effective immediately and should no longer be relied upon."
For an analyst... More
